Delivery Order SPE2DB24D2205-SPE2DB24FDVGD
Award Date 6/7/24
Potential Completion Date 6/10/24
Potential Value $29K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, SPE2DB20D1004|SPE2DB23FF5M8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,348.50, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 30, 2023. There is no set-aside designation mentioned,...
- This federal contract award, with an ID of SPE2DB24D2003|SPE2DB24FXDC7, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,360.47 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 12, 2024 and was awarded on March 11, 2024. It is not designated as a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,909.56 firm fixed price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ55H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,257.15, is a delivery order for the supply of XIFAXAN 550 MG TABLET 60S. The contract has a firm fixed price pricing type and an ultimate completion date of December 13, 2024. The contract award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDSC5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a total ceiling value of $68,618.48. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug...
- This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMJFM, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $27,091.02 and a period of performance through February 19, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,703.10 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, with ID SPE2DB24D2212|SPE2DB25FHPRM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,759.13 delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a performance period extending through May 5, 2025. Amerisourcebergen Drug Corp, the prime contractor, is...
- This federal contract award, with an ID of SPE2DB20D2200|SPE2DB25FW47D, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the provision of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The ultimate completion date for this contract is February 25, 2025, and the ceiling value is $3,466.25. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,858.31, is for the delivery of XIFAXAN 550 MG TABLET UD 60S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...